Susan Hasty, Publisher
Table of Contents . . . November 20th, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Vaccine Weekly | Other Publications
Cancer Vaccine - Stromal cell-derived factor 1 effective against leukemia and melanoma in murine models
Infectious Disease Vaccine - Rotavirus vaccine could protect children from infection and related diarrhea
Childhood Immunization - More resources needed to vaccinate 95% of all children
Influenza Vaccine - Review article covers details involved in developing effective influenza vaccines
Meningitis Vaccine - Meningococcal C conjugate vaccine safe and effective
AIDS Resistance - Study shows why some immune systems control HIV
Appointments - Industry executive named to vaccine developer's board
Cancer Vaccines - Avax Technologies signs distribution agreement
Cancer Vaccines - Clinical trials for melanoma and ovarian cancer receive go-ahead
Finance - Company's third quarter revenue positively affected by HIV, HCV contracts
Immunology - Novel DNA molecules are potent, selective immunoregulators
Influenza - FluINsure vaccine challenge study in U.K. is approved
Influenza Vaccine - Vaccination fails to protect French workers from the flu
Investment Banking - CytRx Corp. announces agreement with Sands Brothers
Lung Cancer - Full commercial rights to GVAX vaccines reacquired
Malaria Vaccine - Reproducible primate malaria transmission model developed by Colombian researchers
Meningitis Vaccine - No serious adverse interactions found MCC vaccines and diphtheria-tetanus booster
Rheumatoid Arthritis - New hope for vaccine to fight RA, other autoimmune disorders
Vaccine Development - Manufacturer in Australia will no longer produce melanoma vaccine
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.